TheraRadar
Data updated: May 26, 2026

StrataGraft (allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen-dsat)

Approved 2021-06-14
1
Indication
--
Phase 3 Trials
4
Years on Market

Details

Status
Disc
First Approved
2021-06-14
Patent Cliff
2033

Pro Metrics

Patent cliff and revenue data

Unlock with Pro
Routes
Topical
Dosage Forms
Cell Sheets

StrataGraft Approval History

2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
1 FDA actions from 2021 to 2021
Jun 2021 ORIGINAL
Update · CBER biologic (Purple Book)

What StrataGraft Treats

1 FDA approvals

Originally approved for its first indication in 2021 .

  • Other (1)
📋

Clinical Trial Registry

1 trials
Trial Sponsor ID Phase Status Title
NCT05517902 StrataSTEPS results posted MNK15011001 Ph 3 completed StrataGraft Safety, Tolerability and Efficacy in Pediatric Subjects
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

StrataGraft FDA Label Details

Track StrataGraft with TheraRadar Pro

Watchlist alerts, full database access, CSV exports across 14,000+ drugs.

Upgrade to Pro

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.